This second of four exclusive episodes explores whether sparsentan can leapfrog renin-angiotensin system (RAS) blockade and how emerging biomarkers may reshape management of IgA nephropathy. Nigwekar: ...

In this special MedPage Today video, leading experts share what they believe is the most troubling or important development ...

The FDA has rehired at least some workers tasked with releasing public records generated by the agency's regulatory ...

This retrospective case series involved a review of medical records at a single tertiary care center. Charbel Issa and ...

"For someone like me, from the Black community who income-wise is on the lower end, we don't often have a voice," said Denver ...

In the 21-study analysis, parental use of technology was negatively associated with cognitive and psychosocial outcomes as ...

The Justice Department announced that a federal jury in Louisiana convicted a nurse practitioner for her part in a Medicare ...

"When you mix politics and science, you just get politics." -- Former NIH director Francis Collins, MD, PhD, on lessons ...

In March, Arkansas asked the Trump administration to relaunch its Medicaid work requirement program. The federal public ...

This message, printed in black on a neon yellow poster board, hangs just outside the $1.1 billion Charlotte R. Bloomberg ...

WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 ...